Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Fielding

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
JAMA|May 29, 2014
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trialMarco Pahor, Jack M Guralnik, Walter T Ambrosius, et al.
Aging Clinical and Experimental Research|May 23, 2023
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric propertiesCharlotte Beaudart, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan, et al.
International Journal of Obesity (2005)|January 9, 2026
The Physiology Of the WEight Reduced State (POWERS) study: design and rationale for assessment of food intake, physical activity and other behavioral constructsLaurel E S Mayer, Michael Lowe, Kelly C Allison, et al.
Aging Clinical and Experimental Research|July 27, 2024
An executive summary on the Global conceptual definition of SarcopeniaBen Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Journal of the American Medical Directors Association|April 30, 2011
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaRoger A Fielding, Bruno Vellas, William J Evans, et al.
Calcified Tissue International|July 25, 2019
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Journal of the American Geriatrics Society|July 8, 2020
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC AnalysisPeggy M Cawthon, Todd Manini, Sheena M Patel, et al.
Age and Ageing|March 23, 2024
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)Ben Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
JAMA|May 29, 2014
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trialMarco Pahor, Jack M Guralnik, Walter T Ambrosius, et al.
Aging Clinical and Experimental Research|May 23, 2023
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric propertiesCharlotte Beaudart, Jean-Yves Reginster, Jotheeswaran Amuthavalli Thiyagarajan, et al.
International Journal of Obesity (2005)|January 9, 2026
The Physiology Of the WEight Reduced State (POWERS) study: design and rationale for assessment of food intake, physical activity and other behavioral constructsLaurel E S Mayer, Michael Lowe, Kelly C Allison, et al.
Aging Clinical and Experimental Research|July 27, 2024
An executive summary on the Global conceptual definition of SarcopeniaBen Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Journal of the American Medical Directors Association|April 30, 2011
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaRoger A Fielding, Bruno Vellas, William J Evans, et al.
Calcified Tissue International|July 25, 2019
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Journal of the American Geriatrics Society|July 8, 2020
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC AnalysisPeggy M Cawthon, Todd Manini, Sheena M Patel, et al.
Age and Ageing|March 23, 2024
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)Ben Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Pageof 25